Compare ASMB & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | GPRK |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 608.0M |
| IPO Year | 2010 | 2009 |
| Metric | ASMB | GPRK |
|---|---|---|
| Price | $29.33 | $9.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $44.20 | $8.50 |
| AVG Volume (30 Days) | 71.4K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | ★ 91.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $39.45 |
| Revenue Next Year | $235.63 | N/A |
| P/E Ratio | ★ N/A | $12.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.68 | $5.75 |
| 52 Week High | $39.71 | $10.34 |
| Indicator | ASMB | GPRK |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 51.37 |
| Support Level | $29.31 | $7.96 |
| Resistance Level | $30.54 | $10.16 |
| Average True Range (ATR) | 1.42 | 0.57 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 70.68 | 55.10 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
GeoPark Ltd is an independent energy company. Its diversified portfolio of assets consist of Llanos 34 Block in Colombia, CPO-5 Block, Llanos 86, Llanos 87, Llanos 104, Llanos 123, and Llanos 124 Blocks in the Llanos Basin. Its segments include Colombia, Argentina, Brazil and Ecuador, with the majority of the revenue derived from Colombia. It derives revenue from Sale of crude oil, Sale of purchased crude oil, and Sale of gas.